{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:20:03Z","timestamp":1761312003513},"reference-count":0,"publisher":"Press of International Journal of Ophthalmology (IJO Press)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Ophthalmol"],"published-print":{"date-parts":[[2023,11,18]]},"abstract":"<jats:p>AIM: To determine the in vitro protective effect of recombinant prominin-1 (Prominin-1)+microRNA-29b (P1M29) on N-methyl-D-aspartate (NMDA)-induced excitotoxicity in retinal ganglion cells (RGCs).\nMETHODS: RGC-5 cells were cultured, and NMDA-induced excitotoxicity at the range of 100\u2013800 \u03bcmol\/L was assessed using the MTT assay. NMDA (800 \u03bcmol\/L) was selected as the appropriate concentration for preparing the cell model. To evaluate the protective effect of P1M29 on the cell model, Prominin-1 was added at the concentration of 1\u20136 ng\/mL for 48h, and the cell survival was investigated with\/without microRNA-29b. After obtaining the appropriate concentration and time of P1M29 at 48h, real-time polymerase chain reaction (PCR) was utilized to detect the relative mRNA expression of vascular endothelial growth factor (VEGF) and transforming growth factor (TGF)-\u03b22. Western blot detection was applied to measure the phosphorylation levels of protein kinase B (AKT) and extracellular regulated protein kinases (ERK) in RGC-5 cells after treatment with Prominin-1. Apoptosis study of the cell model was conducted by flow cytometry for estimating the anti-apoptotic effect of P1M29. Immunofluorescence analysis was used to analyze the expression levels of VEGF and TGF-\u03b22.\nRESULTS: MTT cytotoxicity assays demonstrated that P1M29 group had significantly higher cell survival rate than Prominin-1 group (P&lt;0.05). Real-time PCR data indicated that the expression levels of VEGF were significantly increased in both Prominin-1 and P1M29 groups compared NMDA and microRNA-29b group (P&lt;0.05), while TGF-\u03b22 were significantly decreased in both microRNA-29b and P1M29 groups compared NMDA and Prominin-1 group (P&lt;0.05). Western blot results showed that both Prominin-1 and P1M29 groups significantly increased the phosphorylation levels of AKT and ERK compared to NMDA and microRNA-29b groups (P&lt;0.05). Flow cytometry analysis revealed that P1M29 could prevent RGC-5 cell apoptosis in the early stage of apoptosis, while immunofluorescence results showed that P1M29 group had higher expression of VEGF and lower expression of TGF-\u03b22 with a stronger green fluorescence than NMDA group.\nCONCLUSION: Prominin-1 combined with microRNA-29b can provide a suitable therapeutic option for ameliorating NMDA-induced excitotoxicity in RGC-5 cells.<\/jats:p>","DOI":"10.18240\/ijo.2023.11.03","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T06:50:26Z","timestamp":1698216626000},"page":"1746-1755","source":"Crossref","is-referenced-by-count":2,"title":["In vitro protective effect of recombinant prominin-1 combined with microRNA-29b on N-methyl-D-aspartate-induced excitotoxicity in retinal ganglion cells"],"prefix":"10.18240","volume":"16","author":[{"name":"Eye Hospital and School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, Zhejiang Province, China; Eye Hospital of Wenzhou Medical University Hangzhou Branch, Hangzhou 310020, Zhejiang Province, China","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Hua","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Da","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Eye Hospital and School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, Zhejiang Province, China; Eye Hospital of Wenzhou Medical University Hangzhou Branch, Hangzhou 310020, Zhejiang Province, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Tianjin Eye Hospital, Tianjin 300020, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7543","container-title":["International Journal of Ophthalmology"],"original-title":[],"link":[{"URL":"http:\/\/ies.ijo.cn\/en_publish\/2023\/11\/20231103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T06:50:30Z","timestamp":1698216630000},"score":1,"resource":{"primary":{"URL":"http:\/\/ies.ijo.cn\/gjyken\/ch\/reader\/view_abstract.aspx?file_no=20231103&flag=1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,18]]}},"URL":"https:\/\/doi.org\/10.18240\/ijo.2023.11.03","relation":{},"ISSN":["2222-3959","2227-4898"],"issn-type":[{"type":"print","value":"2222-3959"},{"type":"electronic","value":"2227-4898"}],"subject":[],"published":{"date-parts":[[2023,11,18]]}}}